Thorne Basic Nutrients 2/Day Review

Because a multivitamin's value lives in its FORMS and its TESTING, not its price, and Thorne wins on both. It uses fully methylated folate (L-5-MTHF) and B12 (methylcobalamin) — the active, circulating forms your body uses directly — plus bisglycinate-chelated minerals, and it's NSF certified, meaning an independent body has verified the bottle contains what the label claims. A cheap one-a-day with folic acid and oxide minerals costs less per day but gives you inferior forms and (often) no third-party check. At ~$1.07/day Thorne is a premium, but you're paying for exactly the two things that determine whether a multivitamin is any good.

For most people it's a feature, not a bug. Men and post-menopausal women generally do NOT need supplemental iron and can slowly accumulate too much from iron-containing multis, so a deliberately iron-free formula is the safer default for them. The exception is menstruating women, who lose iron monthly and often genuinely need it — if that's you, either pair Thorne with a separate iron supplement (ideally after a blood test confirms you need it) or choose an iron-containing women's multivitamin like Ritual or Garden of Life Women's. Don't take iron you don't need just to 'be safe' — that's how iron overload happens.

It means the nutrients are in forms your body can use immediately. 'Methylated' refers to folate as L-5-MTHF and B12 as methylcobalamin — the active forms, versus folic acid and cyanocobalamin which must be enzymatically converted first (a step many people do inefficiently, per Pietrzik 2010). 'Chelated' means the minerals (calcium, magnesium, zinc) are bound to glycine as bisglycinates, which are gentler on the stomach and better absorbed than cheap oxides. In practice: better absorption, less GI upset, and effectiveness that doesn't depend on how well your particular genetics convert folate.

Be realistic. Thorne is an excellent multivitamin, but no multivitamin is a longevity drug — the largest trial (PHS II, 14,641 men over 11+ years) found a multivitamin produced no reduction in cardiovascular events or death, alongside a modest 8% drop in total cancer incidence (Gaziano 2012; Sesso 2012). What a high-quality multivitamin like this genuinely does is fill the dietary gaps a real diet leaves, in forms you can use. If you have gaps (and national data say most people do), that's worthwhile insurance. If you already eat a varied, nutrient-dense diet, the marginal benefit is small. Buy it as good insurance, not as a health transformation.

You can, but you'll get roughly half the intended gap-filling. The formula is designed as a two-capsule daily serving (that's how it delivers a full, balanced top-up without megadosing any single nutrient), so two is the dose to match the label. If pill count is a real obstacle for you, that's a legitimate reason to prefer a true once-daily like Pure Encapsulations O.N.E. (one capsule) or MegaFood One Daily (one tablet) instead — the best multivitamin is the one you'll actually take consistently. But if you can manage two capsules, Thorne's forms and testing make it worth it.

1. [1] Pietrzik 2010 PMID 20608755 — Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. L-5-methyltetrahydrofolate (methylfolate) is the active, circulating folate, while folic acid is a synthetic that must be enzymatically converted — a step many do inefficiently. The basis for crediting Thorne's L-5-MTHF folate as a genuine quality advantage.
2. [2] Gaziano 2012 (PHS II — cancer) PMID 23162860 — Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. 14,641 men, 11.2 years: a daily multivitamin produced a modest 8% reduction in total cancer incidence. Cited to size the realistic upside honestly — a small long-run cancer-incidence edge, not a health transformation.
3. [3] Sesso 2012 (PHS II — cardiovascular) PMID 23117775 — Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. Same cohort: NO reduction in major cardiovascular events or death. The null result behind the honest framing — even the best multivitamin is gap-insurance, not a cardiovascular or longevity drug.